Migraine and Tension-Type Headache Reduction Through Pericranial Muscular Suppression: A Preliminary Report

Cranio - Journal of Craniomandibular and Sleep Practice

Volumn 19, Issue 4, 2001, Pages 269-278

  Shankland II, Wesley E ^a,b,c,d  

^a OHIO STATE UNIVERSITY   (United States)

^b Amer Academy of Craniofacial Pain ^*  (United States)

^c Amer Academy of Craniofacial Pain   (United States)

^d Christian Medical and Dental Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PLACEBO; SEROTONIN AGONIST; SUMATRIPTAN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTAL EQUIPMENT; EQUIPMENT; EQUIPMENT DESIGN; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; MEDICAL RECORD; MIGRAINE; NERVE CELL INHIBITION; NOCICEPTIVE RECEPTOR; PAIN ASSESSMENT; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SAFETY; STATISTICS; TENSION HEADACHE; TOOTH OCCLUSION; TRIGEMINAL NERVE; UNITED STATES;

ANALGESICS; DENTAL OCCLUSION, CENTRIC; DEVICE APPROVAL; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIGRAINE DISORDERS; NEURAL INHIBITION; NOCICEPTORS; OCCLUSAL SPLINTS; PAIN MEASUREMENT; PLACEBOS; SEROTONIN AGONISTS; STATISTICS; SUMATRIPTAN; TENSION-TYPE HEADACHE; TRIGEMINAL NERVE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0035488320     PISSN: 08869634     EISSN: None     Source Type: Journal    
DOI: 10.1080/08869634.2001.11746178     Document Type: Article

References (85)

1. Lipton RB, Stewart WF: Migraine in the United States: a review of epidemiology and health care use. Neurology 1993; 43(6 suppl 3):S6-S10.
2. Saper JR, Siberstein S, Gordon CD, Hamel RL: Handbook of headache management. Baltimore: Williams & Wilkins, 1993.
3. Stewart WF, Lipton RB, Celentano DD, Reed ML: Prevalence of migraine headache in the United States. JAMA 1992; 267:64-69.
4. Hu XH, Markson LE, Lipton RB, Stewart W, Berger ML: Burden of migraine in the United States. Arch Intern Med 1999; 159:813-818.
5. Headache classification committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial nerve neuralgias, and facial pain. Cephalalgia 1988;8(suppl 7):1-96.
6. Linet MS, Stewart WF, Celentano DE, et al.: An epidemiological study of headache among adolescents and young adults. JAMA 1989; 261:2211-2216.
7. Ryan, RE Sr, Ryan RE Jr.: Headache and head pain. St. Louis: CV Mosby Co, 1978.
8. Shankland WE: The differential diagnosis of headaches. J Craniomandib Pract 1986; 4:47-53.
9. Wolff HG: Headache and other head pain. New York: Oxford University Press, 1947.
10. Olesen J, Tfelt-Hansen P, Hendricksen L, Larsen B: The common migraine attack may not be initiated by cerebral ischemia. Lancet 1981; 2:438-440.
11. Goadsby PJAU, Hoskin KL: Serotonin inhibits trigeminal nucleus evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine? Ann Neurol 1998; 43:711-718.
12. Buzzi MG, Bonamini M, Moskowitz MA: Neurogenic model of migraine. Cephalalgia 1995; 15:377-280.
13. Welch KM, Barkley GL, Tepley N, Ramadan NM: Central neurogenic mechanisms of migraine. Neurology 1993; 43(6 suppl 3): S21-S25.
14. Moskowitz MA: Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43(suppl 3): S16-S20.
15. Salvesen R: Current viewpoints on etiology and physiopathology of migraine. Tidsskr Nor Laegeforen 1999; 119:1437-1443.
16. Sulman FG: Migraine and headache due to weather and allied causes and its specific treatment. Ups J Med Sci Suppl 1980; 31:41-44.
17. Moskowitz MA, Buzzi MG, Sakas DE, Linnik MD: Pain mechanisms underlying vascular headaches. Progress Report 1989. Rev Neurol (Paris) 1989; 145:181-193.
18. Rasmussen BK: Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993; 53:65-72.
19. Welch KM, Barkley GL, Tepley N, Ramadan NM: Central neurogenic mechanisms of migraine. Neurology 1993; 43(6 Suppl 3):S21-25.
20. Moss RA: A structural imbalance/muscular hyperactivity interactional theory of common migraine pain. J Craniomandib Pract 1988; 6:87-88.
21. Diamond S, Freitag FG: The importance of the history in the diagnosis of headache and facial pain. J Craniomand Pract 1986; 4:197-198.
22. Benoliel R, Sharav Y: Paroxysmal hemicrania. Case studies and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85:285-292.
23. Lous I, Olesen J: Evaluation of pericranial tenderness and oral function in patients with common migraine, muscle contraction headache and "combination headache." Pain 1982; 12:385-393.
24. Lipchik GL, Holroyd KA, France CR, Kvaal SA, Segal D, Cordingley GE, Rokicki LA, McCool HR: Central and peripheral mechanisms in chronic tension-type headache. Pain 1996; 64:467-475.
25. Ruff GA, Moss RA, Lombardo TW: Common migraine: a review and proposal for a non-vascular aetiology. J Oral Rehabil 1986; 13:499-508.
26. Moskowitz MA, Buzzi MG: Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 1991; 238 Suppl 1:S18-22.
27. Ziegler DK: An overview of the classification, causes, and treatment of headache. Hosp Community Psychiatry 1984; 35:263-267.
28. Kim HS, Chung SC, Kim YK, Lee SW: Pain-pressure threshold in the head and neck region of episodic tension-type headache patients. J Orofac Pain 1995; 9:357-364.
29. Moncada E, Graff-Radford SB: Benign indomethacin-responsive headaches presenting in the orofacial region: eight case reports. J Orofac Pain 1995; 9:276-284.
30. Delcanho RE, Graff-Radford SB: Chronic paroxysmal hemicrania presenting as toothache. J Orofac Pain 1993; 7:300-306.
31. Lamey PJ, Steele JG, Aitchison T: Migraine: the effect of acrylic appliance design on clinical response. Br Dent J 1996; 180:137-140.
32. Magnusson T, Carlsson GE: Changes in recurrent headaches and mandibular dysfunction after various types of dental treatment. Acta Odontol Scand 1980; 38:311-320.
33. Bailey DR: Tension headache and bruxism in the sleep disordered patient. J Craniomandib Pract 1990; 8:174-182.
34. Molina OF, dos Santos J Jr, Nelson SJ, Grossman E: Prevalence of modalities of headaches and bruxism among patients with craniomandibular disorder. J Craniomandib Pract 1997; 15:314-325.
35. Wieselmann G, Grabmair W, Logar C, Perman R, Flooh E, Lechner H: EEG studies in bruxism with headache patients. EEG EMG Z Elektroenzephalogr Verwandte Geb 1987; 18:135-137.
36. Schepelmann K, Dannhausen M, Kotter I, Schabet M, Dichgans J: Exteroceptive suppression of temporalis muscle activity in patients with fibromyalgia, tension-type headache, and normal controls. Electroencephalogr Clin Neurophysiol 1998; 107:196-199.
37. Paulus W, Raubuchl O, Straube A, Schoenen J, Exteroceptive suppression of temporalis muscle activity in various types of headache. Headache 1992; 32:41-44.
38. Neufeld JD, Holroyd KA, Lipchik GL: Dynamic assessment of abnormalities in central pain transmission and modulation in tension-type headache sufferers. Headache 2000; 40:142-151.
39. Zwart JA, Sand T: Exteroceptive suppression of temporalis muscle activity: a blind study of tension-type headache, migraine, and cervicogenic headache. Headache 1995; 35:338-343.
40. Wang W, De Pasqua V, Gerard P, Schoenen J: Specificity and sensitivity of temporalis ES2 measurements in the diagnosis of chronic primary headaches. Headache 1995; 35:85-88.
41. Jones CM: Chronic headache and nocturnal bruxism in a 5-year-old child treated with an occlusal splint. Int J Paediatr Dent 1993; 3:95-97.
42. Holmgren K, Sheikholeslam A, Riise C, Kopp S: The effects of an occlusal splint on the electromyographic activities of the temporal and masseter muscles during maximal clenching in patients with a habit of nocturnal bruxism and signs and symptoms of craniomandibular disorders. J Oral Rehabil 1990; 17:447-459.
43. Hamada T, Kotani H, Kawazoe Y, Yamada S: Effect of occlusal splints on the EMG activity of masseter and temporal muscles in bruxism with clinical symptoms. J Oral Rehabil 1982; 9:119-123.
44. Boyd IP, Shankland WE: Brown C, Schames J: Taming destructive forces using a tension suppression device. Postgrad Dent 2000; 7:1-4.
45. Waters WF, McAnulty DP, Buss RR: The Autonomic Nervous System Response Inventory (ANSRI): discrimination among migraine headache sufferers, muscle contraction headache sufferers, and normal controls. J Psychosom Res 1989; 33:349-559.
46. Pogacnik T, Sega S, Mesec A, Kiauta T: Autonomic function testing in patients with tension-type headache. Headache 1993; 33:63-68.
47. Appel S, Kuritzky A, Zahavi I, Zigelman M, Akselrod S: Evidence for instability of the autonomic nervous system in patients with migraine headache. Headache 1992; 32:10-17.
48. Goadsby PJ: Short-lasting primary headaches: focus on trigeminal automatic cephalgias and indomethacin-sensitive headaches. Curr Opin Neurol 1999; 12:273-277.
49. De Marinis M, Feliciani M, Janiri L, Cerbo R, Agnoli A: Increased reactivity to a met-enkephalin analogue in the control of autonomic responses in migraine patients. Clin Neuropharmacol 1990; 13:507-521.
50. Hubbard DR, Berkoff GM: Myofascial trigger points show spontaneous needle EMG activity. Spine 1993; 18:1803-1807.
51. Clark GT, et al, Waking and sleeping temporalis EMG levels in tension-type headache patients. J Orofac Pain 1997; 11(4)Fall:298-306.
52. Silberstein S, Botulinum toxin type A as a migraine preventive treatment. Headache 2000; 40(6) Jun:445-450.
53. Travell JG, Simons DG: Myofascial pain and dysfunction. Volume 1 Baltimore: Williams & Wilkins, 1983:4.
54. Lamey PJ, et al, Migraine: the effect of acrylic appliance design on clinical response. Br Dent J 1996; 180(4) Feb:137-140.
55. Kolta A, Dubuc R, Lund JP: An immunocytochemical and autoradiographic investigation of the serotoninergic innervation of trigeminal mesencephalic and motor nuclei in the rabbit. Neurosci 1993; 53:1113-1126.
56. Shankland WE, Negulesco JA, O'Brien B: The "pre-anterior belly" of the temporalis muscle: a preliminary study of a newly described muscle. J Craniomandib Pract 1996; 14:106-111
57. Dunn GF, Hack GD, Robinson WL, Koritzer RT: Anatomical observation of a craniomandibular muscle originating from the skull base: the sphenomandibularis. J Craniomandib Pract 1996; 14:97-103.
58. Blau JN: Migraine triggers: practice and theory. Pathol Biol (Paris) 1992; 40:367-372.
59. Clifford T, Lamey PJ, Fartash L: Mandibular tori, migraine and temporomandibular disorders. Br Dent J 1996; 180:382-384.
60. Wieselmann G, Grabmair W, Logar C, Perman R, Flooh E, Lechner H: EEG studies in bruxism with headache patients. EEG EMG Z Elektroenzephalogr Verwandte Geb 1987; 18:135-137.
61. Steele JG, Lamey PJ, Sharkey SW, Smith GM: Occlusal abnormalities, pericranial muscle and joint tenderness and tooth wear in a group of migraine patients. J Oral Rehabil 1991; 18:453-458.
62. Modin MU, Pernow JAU, Lundberg JM: Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y. Acta Physiol Scand 1993; 148:1-11.
63. Grande PO: Influence of neural and humoral beta-adrenoceptor stimulation on dynamic myogenic microvascular reactivity in cat skeletal muscle. Acta Physiol Scand 1979; 106:457-465.
64. Saltin B: Capacity of blood flow delivery to exercising skeletal muscle in humans. Am J Cardiol 1988; 62:30E-35E.
65. Meininger GA, Faber JE: Adrenergic facilitation of myogenic response in skeletal muscle arterioles. Am J Physiol 1991; 260(5 Pt 2):H1424-H1432.
66. Dornyei G, Monos E, Kaley G, Koller A: Myogenic responses of isolated rat skeletal muscle venule: modulation by norepinephrine and endothelium. Am J Physiol 1996; 271(1 Pt2):H267-H272.
67. Maeda S, Miyauchi T, Sakane M, Saito M, Maki S, Goto K, Matsuda M: Does endothelin-1 participate in the exercise-induced changes of blood flow distribution of muscles in humans? J Appl Physiol 1997; 82:1107-1111.
68. Grassi C, Filippi GM, Passatore M: Postsynaptic alpha 1 and alpha 2 adrenoceptors mediating the action of the sympathetic system on muscle spindles in the rabbit. Pharmacol Res Commun 1986; 18:161-170.
69. Grassi C, Passatore M: Spontaneous sympathetic command to skeletal muscles: functional implications. Funct Neurol 1990; 5:227-231
70. Hubbard DR, Berkoff GM: Myofascial trigger points show spontaneous needle EMG activity. Spine 1993; 18:1803-1807.
71. Wallin B, Thompson JM, Jennings GL, Esler MD: Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol (Lond) 1996; 491:881-887.
72. Grassi C, Deriu F, Roatta S, Santarelli R, Azzena GB, Passatore M: Sympathetic control of skeletal muscle function: possible cooperation between noradrenaline and neuropeptide Y in rabbit jaw muscles. Neurosci Lett 1996; 212:204-208.
73. Anthony M: Biochemical Indices of sympathetic activity in migraine. Cephalalgia 1981; 1:83-89.
74. Clark GT, Beemsterboer PL, Rugh JD: Noctural masseter muscle activity and the symptoms of masticatory dysfunction. J Oral Rehabil 1981; 8:279-286.
75. Abraham J, Pierce C, Rinhuse D, Zullo T: Assessment of buccal separators in the relief of bruxist activity associated with myofascial pain-dysfunction. Angle Orthod 1992; 62:177-184.
76. Nassif NJ, al-Ghamdi KS: Managing bruxism and temporomandibular disorders using a centric relation occlusal device. Campend Contin Educ Dent 1999; 20:1071-1074.
77. Dao TT, Lavigne GJ: Oral splints: the crutches for temporomandibular disorders and bruxism? Crit Rev Oral Biol Med 1998; 9:345-361.
78. Clark GT: A critical evaluation of orthopedic interocclusal appliance therapy: effectiveness for specific symptoms. JADA 1984; 108:364-368.
79. Pierce CJ, Gale EN: A comparison of different treatments for nocturnal bruxism. J Dent Res 1988; 67:597-601.
80. Holmgren K, Sheikholeslam A, Riise C, Kopp S: The effects of an occlusal splint on the electromyographic activities of the temporal and masseter muscles during maximal clenching in patients with a habit of nocturnal bruxism and signs and symptoms of craniomandibular disorders. J Oral Rehabil 1990; 17:447-459.
81. Sheikholesiam A, Holmgren K, Riise C: Therapeutic effects of the plane occlusal splint on signs and symptoms of craniomandibular disorders in patients with nocturnal bruxism. J Oral Rehabil 1993; 20:473-482.
82. Holmgren K, Sheikholeslam A, Riise C: Effect of a full-arch maxillary splint on parafunctional activity during sleep in patients with nocturnal bruxism and signs and symptoms of craniomandibular disorders. J Prosthet Dent 1993; 69:293-297.
83. Quayle AA, Gray RJ, Metcalfe RJ, Guthrie E, Wastell D: Soft occlusal splint therapy in the treatment of migraine and other headaches. J Dent 1990; 18:123-129.
84. Zetz MR, Kaufman HB: Nonsurgical management of TMJ disorders. In: Current advances in oral surgery. volume III, Irby WB ed. St. Louis: CV Mosby Co, 1980:253-283.
85. Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, Rapoport AM, Silber CJ, Deaton RL: Migraine prophylaxis with divalproex. Arch Neurol 1995; 52:281-286.